Get started
Author

Jesús Martínez Cadilla

Observed names: J Cadilla, J Martinez Cadilla, J Martinez.Cadilla, J Martínez Cadilla, J Martínez-Cadilla, J. Cadilla, J. Cadillá, J. Martinez Cadilla, J. Martínez Cadilla, J. Martínez-Cadilla, J. Martínez‐Cadilla, Jesus Cadillá, Jesús Cadillá, Jesús Martinez Cadilla, Jesús Martínez Cadilla
Observed institutions: University Hospital Complex Of Vigo, Hospital Universitario de La Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Southeast Louisiana Veterans Health Care System, Servicio Gallego de Salud, Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa, Unidade Local de Saúde do Algarve, Estructura Organizativa de Xestión Integrada de Vigo, Universidade de Vigo, Universidad Autónoma de Madrid
ORCID: 0000-0002-8091-9433
Observed ORCID: 0000-0002-8091-9433
OpenAlex ID: A5036018142
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study
2022 · María Chaparro, Iria Baston-Rey, et al. · Inflammatory Bowel Diseases · 70
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
2022 · María Chaparro, Diana Acosta, et al. · The American Journal of Gastroenterology · 36
Olmesartan-Induced Enteropathy: An Unusual Cause of Villous Atrophy
2015 · Marta Eusébio, Paulo Caldeira, et al. · GE Portuguese Journal of Gastroenterology · 18
PDF
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
2022 · María Chaparro, Iria Baston-Rey, et al. · Journal of Clinical Medicine · 11
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
2019 · María Chaparro, María G. Donday, et al. · Therapeutic Advances in Gastroenterology · 7
Long‐term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
2024 · María Chaparro, Sandra Hermida, et al. · Alimentary Pharmacology & Therapeutics · 6
PDF
Sensitivity of Ultrasonography for Gastric Cancer Diagnosis in Symptomatic Patients
2008 · David Martinez-Ares, Pedro A. Alonso Aguirre, et al. · Digestive Diseases and Sciences · 6
Russell body gastritis in an Hp-negative patient
2016 · Artur Gião Antunes, Jesus Cadillá, et al. · BMJ Case Reports · 5
PDF
Post‐Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU
2026 · J. L. Rueda García, C. Suárez Ferrer, et al. · Alimentary Pharmacology & Therapeutics · 4
Prevalencia de hemocromatosis en trabajadores sanos: Importancia de añadir en la analítica de perfil bioquímico una saturación de transferrina
2000 · C. Martínez-Vázquez, J. Martínez Cadilla, et al. · Anales de Medicina Interna · 4
PDF
Gastric siderosis as a cause of dyspepsia
2016 · Artur Gião Antunes, Jesus Cadillá, et al. · BMJ Case Reports · 3
PDF
Effectiveness and safety of dual advanced therapy in inflammatory bowel disease ? A multicenter series from Galicia, Spain
2025 · M.� Teresa Diz-Lois Palomares, Carmen Pradera Cibreiro, et al. · Revista Española de Enfermedades Digestivas · 2
P741 Incidence and clinical phenotype of inflammatory bowel disease in the north–west of Spain (Vigo) between 1991 and 2011
2020 · M L De Castro Parga, V De Castro Luisa Hernández, et al. · Journal of Crohn s and Colitis · 2
PDF
P661 Clinical characteristics of inflammatory bowel disease in elderly patients
2013 · J. Cadilla, R. Ferreiro, et al. · Journal of Crohn s and Colitis · 2
Utilidad de la ecografía en la valoración de la extensión de la colitis ulcerosa
2007 · D. Martínez Ares, J. Martínez Cadilla, et al. · Revista Española de Enfermedades Digestivas · 2
PDF
Tumor estromal gástrico de riesgo intermedio: diagnóstico mediante ecografía hidrogástrica
2006 · David Martínez-Ares, Jesús Martínez Cadilla, et al. · Gastroenterología y Hepatología · 2
P675 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases
2023 · M Chaparro, D Acosta, et al. · Journal of Crohn s and Colitis · 1
P373 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, impact of extraintestinal manifestations and immunomediated diseases and safety
2022 · M Chaparro, D Acosta, et al. · Journal of Crohn s and Colitis · 1
P263 Influence of Crohn′s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study
2021 · M Chaparro, I Bastón Rey, et al. · Journal of Crohn s and Colitis · 1
PDF
P629 Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn’s disease (CD) in real life: Interim analysis of the SUSTAIN study
2020 · M Chaparro, S Sulleiro, et al. · Journal of Crohn s and Colitis · 1
PDF
Diarrea crónica y trombosis venosa profunda durante el tratamiento con olmesartán
2017 · A. Gião Antunes, A.M. Vaz, et al. · Revista de Gastroenterología de México · 1
PDF
Recurrencia Posquirúrgica De La Enfermedad De Crohn Tras Colectomía: Estudio Resecol Del Grupo Joven De Geteccu
2026 · José Luis Rueda García, Cristina Suárez Ferrer, et al. · Gastroenterología y Hepatología
Calprotectina Fecal Como Predictor De Brote En Proctitis Ulcerosa: Resultados De Un Estudio Prospectivo Multicéntrico
2026 · Rocío Ferreiro-Iglesias, Laura Nieto García, et al. · Gastroenterología y Hepatología
80 - Prevalencia De Uso Y Exceso De Uso De Corticoides En Pacientes Con Eii En Un Centro De Tercer Nivel
2026 · Vicent Hernández Ramírez, Sara Campos Cancela, et al. · Gastroenterología y Hepatología
P0021 SRB5 (anti-CCR9) shows superior ex vivo activity versus a clinically advanced anti-CCR9 benchmark in IBD
2026 · L Arosa García, B Malvar Fernández, et al. · Journal of Crohn s and Colitis
Works count: 43
Citation count: 185
H-index: 6
I10-index: 4
Year
Topic
Type